These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2630174)

  • 21. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
    Dienus K; Bayat A; Gilmore BF; Seifert O
    Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The distribution of hyaluronan in human skin and mature, hypertrophic and keloid scars.
    Bertheim U; Hellström S
    Br J Plast Surg; 1994 Oct; 47(7):483-9. PubMed ID: 7524987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative study of collagen in hypertrophic and keloid cicatrix].
    Podobed OV; Prozorovskiĭ NN; Kozlov EA; Tsvetkova TA; Vozdvizhenskiĭ SI; Del'vig AA
    Vopr Med Khim; 1996; 42(3):240-5. PubMed ID: 9139458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The expression of tenascin-C mRNA in keloids and hypertrophic scars].
    Han CM; He XJ; Ma Q
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2005 Jan; 21(1):40-3. PubMed ID: 15844597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study on the expression of tenascin-C in keloid and hyperplastic scar].
    He XJ; Han CM
    Zhonghua Shao Shang Za Zhi; 2004 Apr; 20(2):79-81. PubMed ID: 15312467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids.
    Kischer CW; Thies AC; Chvapil M
    Hum Pathol; 1982 Sep; 13(9):819-24. PubMed ID: 7106747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential p63 and p53 expression in human keloid fibroblasts and hypertrophic scar fibroblasts.
    De Felice B; Ciarmiello LF; Mondola P; Damiano S; Seru R; Argenziano C; Nacca M; Santoriello M; Garbi C
    DNA Cell Biol; 2007 Aug; 26(8):541-7. PubMed ID: 17688405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of superpulsed carbon dioxide laser energy on keloid and normal dermal fibroblast secretion of growth factors: a serum-free study.
    Nowak KC; McCormack M; Koch RJ
    Plast Reconstr Surg; 2000 May; 105(6):2039-48. PubMed ID: 10839401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different metabolism of hexose sugars and sucrose in wound fluid and in fibroblast cultures derived from granulation tissue, hypertrophic scar and keloid.
    Kössi J; Laato M
    Pathobiology; 2000; 68(1):29-35. PubMed ID: 10859528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implants of keloid and hypertrophic scars into the athymic nude mouse: changes in the glycosaminoglycans of the implants.
    Shetlar MR; Shetlar CL; Kischer CW; Pindur J
    Connect Tissue Res; 1991; 26(1-2):23-36. PubMed ID: 1905609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asiaticoside suppresses collagen expression and TGF-β/Smad signaling through inducing Smad7 and inhibiting TGF-βRI and TGF-βRII in keloid fibroblasts.
    Tang B; Zhu B; Liang Y; Bi L; Hu Z; Chen B; Zhang K; Zhu J
    Arch Dermatol Res; 2011 Oct; 303(8):563-72. PubMed ID: 21240513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA binding proteins from keloid fibroblasts form unique complexes with the human fibronectin promoter.
    Sible JC; Eriksson E; Oliver N
    Gene Expr; 1996; 5(6):269-83. PubMed ID: 8836736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: An objective histopathological analysis.
    Verhaegen PD; van Zuijlen PP; Pennings NM; van Marle J; Niessen FB; van der Horst CM; Middelkoop E
    Wound Repair Regen; 2009; 17(5):649-56. PubMed ID: 19769718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. mTOR as a potential therapeutic target for treatment of keloids and excessive scars.
    Ong CT; Khoo YT; Mukhopadhyay A; Do DV; Lim IJ; Aalami O; Phan TT
    Exp Dermatol; 2007 May; 16(5):394-404. PubMed ID: 17437482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth kinetics and collagen synthesis of normal skin, normal scar and keloid fibroblasts in vitro.
    Diegelmann RF; Cohen IK; McCoy BJ
    J Cell Physiol; 1979 Feb; 98(2):341-6. PubMed ID: 422662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression and significance of mRNA and protein of eIF4E, p-eIF4E and MCl-1 in pathological scar].
    Wu WY; Zhang LT; Zheng ZF; Zhu SZ; Wang ZY
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2012 Sep; 28(5):360-5. PubMed ID: 23259313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hypertrophic scar and keloid. I. Etiology, pathogenesis, pathology].
    Salamon A
    Morphol Igazsagugyi Orv Sz; 1984 Oct; 24(4):262-7. PubMed ID: 6513952
    [No Abstract]   [Full Text] [Related]  

  • 38. [The role of myofibroblast in the development of pathological scar].
    Liu Y; Cen Y; Ying T; Xu X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Jan; 19(1):39-41. PubMed ID: 15704840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
    Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
    Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulsed dye laser versus long-pulsed Nd:YAG laser in the treatment of hypertrophic scars and keloid: A comparative randomized split-scar trial.
    Al-Mohamady Ael-S; Ibrahim SM; Muhammad MM
    J Cosmet Laser Ther; 2016 Aug; 18(4):208-12. PubMed ID: 26735516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.